| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/23/2004 | WO2004019921A3 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases |
| 09/23/2004 | WO2004016744A3 Treatment of liver deseases |
| 09/23/2004 | WO2004009781A3 Process for regulating gene expression |
| 09/23/2004 | WO2004009625A3 PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF α-SYNUCLEIN-RELATED DISEASES |
| 09/23/2004 | WO2004007671A3 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A CLLD8 PROTEIN |
| 09/23/2004 | WO2004005472A3 Inhibitors of ftsz and uses thereof |
| 09/23/2004 | WO2003104414A3 Artificial transcription factors |
| 09/23/2004 | WO2003104395A3 Receptors and membrane-associated proteins |
| 09/23/2004 | WO2003104273A3 Therapeutic epitopes and uses thereof |
| 09/23/2004 | WO2003103601A3 Methods of diagnosing & treating diabetes and insulin resistance |
| 09/23/2004 | WO2003095671A8 Method of diagnosis and treatment for affective disorders |
| 09/23/2004 | WO2003095611A3 Androgen-regulated pmepa1 and cancer |
| 09/23/2004 | WO2003093294A3 Conformationally constrained peptides that bind the orl-1 receptor |
| 09/23/2004 | WO2003087815A3 Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein |
| 09/23/2004 | WO2003086175A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/23/2004 | WO2003086174A3 A new method for the diagnosis and prognosis of malignant diseases |
| 09/23/2004 | WO2003085096A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/23/2004 | WO2003085088A3 Pkhd1, the polycystic kidney and hepatic disease 1 gene |
| 09/23/2004 | WO2003076647A3 Jade nucleic acids, proteins and uses thereof |
| 09/23/2004 | WO2003068809A8 An herpes simplex virus complex |
| 09/23/2004 | WO2003064449A3 Bioactive keratin peptides |
| 09/23/2004 | WO2003063782A3 Kappa-pviia-related conotoxins as organ protectants |
| 09/23/2004 | WO2003061681A3 Proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 09/23/2004 | WO2003061581A3 Compositions and methods for regulating rna stability using polypyrimidine tract proteins |
| 09/23/2004 | WO2003060103A3 Minimal dna binding domain polynucleotides, polypeptides, and uses thereof |
| 09/23/2004 | WO2003059436A3 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 09/23/2004 | WO2003033652A3 TUMOR ENDOTHELIAL MARKER 5α MOLECULES AND USES THEREOF |
| 09/23/2004 | WO2003029262A3 The human mob-5 (il-24) receptors and uses thereof |
| 09/23/2004 | WO2003020956A3 Nucleid acid compositions conferring herbicide resistance |
| 09/23/2004 | WO2003020907A3 Histamine receptor h4 polynucleotides |
| 09/23/2004 | WO2003011209A8 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes |
| 09/23/2004 | WO2003005956A3 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 09/23/2004 | WO2002101059A3 Transgenic plants synthesising high amylose starch |
| 09/23/2004 | WO2002094988A3 Lipid-associated molecules |
| 09/23/2004 | WO2002086124A8 Human chemokine-13 |
| 09/23/2004 | WO2002024151A3 A method of use of sonic hedgehog protein as a ligand for patched |
| 09/23/2004 | US20040187172 Transgenic animal for screening therapeutic agents for brain tumors |
| 09/23/2004 | US20040186280 Comprises brachyspira membrane protein B (BmpB) for diagnosing and treating swine dysentery; veterinary medicine |
| 09/23/2004 | US20040186276 Proteins and DNA related to salt tolerance in plants |
| 09/23/2004 | US20040186275 Sarcomere binding polypeptide for use in diagnosis and treatment of diabetes and cardiomyopathies; diuretics; vasodilation; antiarrhythmic agents |
| 09/23/2004 | US20040186274 Methylation of histone h4 at arginine 3 |
| 09/23/2004 | US20040186272 Comprises microbiocidal cationic amino acid sequence for prevention of respiratory and pulmonary infections |
| 09/23/2004 | US20040186271 Thrombin generation inhibitors |
| 09/23/2004 | US20040186071 Oligonucleotides or polynucleotides; screening for a drug candidate of an immunomodulator for CD40; reducing IL-12 cytokine production, treating inflammation disease; peptide nucleotide acid, modified nucleotides |
| 09/23/2004 | US20040186070 Increased production of secreted proteins by recombinant eukaryotic cells |
| 09/23/2004 | US20040186068 Introduction of an alteration to the polypeptide to form an altered polypeptide; the assembly of a multiplicity of transcriptional regulatory factors on the altered polypeptide to form a controllable platform; and the specific targeting of the controllable platform to a plurality of promoters |
| 09/23/2004 | US20040186057 Synthetic single domain polypeptides mimicking apolipoprotein E and methods of use |
| 09/23/2004 | US20040186056 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 09/23/2004 | US20040186053 Having a molecular weight of about 72 kDa, being a single chain protein with an N-terminal amino acid sequence of Leu Ala Pro Ser Pro Gln Ser Pro Glu Thr 1 5 10 Pro Ala [SEQ ID NO:16], and producing rapid inhibition of factor Xa in the presence of protein Z, calcium ions and cephalin. |
| 09/23/2004 | US20040186051 Apo-2 ligand variants and uses thereof |
| 09/23/2004 | US20040186048 Gene regulation therapy involving ferritin |
| 09/23/2004 | US20040186047 Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing |
| 09/23/2004 | US20040185566 Comprises nucleotide sequences coding serratia metalloprotease (SMP) for transformation and generation of parasite resistant plants; parasiticide; nematocide; biological pest control |
| 09/23/2004 | US20040185563 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 09/23/2004 | US20040185555 Viral vector coding lymphadenopathy associated antigens and devoid of early gene sequences for transfer and expression of heterologous gene sequences; vaccine development |
| 09/23/2004 | US20040185548 Hybrid receptors for efficient assay of modulators of receptor protein-tyrosine kinases |
| 09/23/2004 | US20040185547 undergo ligand-mediated receptor dimerization; determined by x-ray diffraction |
| 09/23/2004 | US20040185536 Methods for differentiating and monitoring parathyroid and bone status related diseases |
| 09/23/2004 | US20040185533 Corticotropin-releasing factor2 receptors |
| 09/23/2004 | US20040185531 for use in biosensors/bioreactors; for drug screening; solid phase synthesis; genetic engineering |
| 09/23/2004 | US20040185527 Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and uses thereof |
| 09/23/2004 | US20040185525 Process for producing peptide |
| 09/23/2004 | US20040185508 Methods and reagents for modulating cholesterol levels |
| 09/23/2004 | US20040185505 Cytostatin II |
| 09/23/2004 | US20040185503 Administering peroxisome proliferator-activated receptor agonist; assaying substance for up-regulating the expression of fatty acid-binding protein; glomerulonephritis, nephrotic syndrome, focal glomerulosclerosis |
| 09/23/2004 | US20040185501 Purified human nucleic acid of given sequence; screening for compounds that bind to metabotropic glutamate receptor gene; expression vectors |
| 09/23/2004 | US20040185500 Use of disease-associated gene |
| 09/23/2004 | US20040185496 Anti-bacterial methods and materials |
| 09/23/2004 | US20040185494 Human FGF-21 gene and gene expression products |
| 09/23/2004 | US20040185492 DNA chip, PNA chip, and their preparation methods |
| 09/23/2004 | US20040185469 Isolated (T1R1/T1R3) umami taste receptors that respond to umami taste stimuli |
| 09/23/2004 | US20040185468 Promoter variants of the alpha-7 nicotinic acetylcholine receptor |
| 09/23/2004 | US20040185463 for drug screening which inhibit activation of cAMP and mitogen responsive genes and methods for the identification of novel signal dependent transcription factors and co-factor proteins |
| 09/23/2004 | US20040185456 for drug screening treatment or prevention of obesity, hypertriglyceridemia, or, in the field of cardiovascular conditions, myocardial infarction, angina, sudden death, cardiac decompensation and cerebrovascular accidents |
| 09/23/2004 | US20040185450 Comprises nucleotide sequences coding macrophage chemoattractant protein-1 for prevention and treatment of psychological and cell proliferative disorders |
| 09/23/2004 | US20040185442 Novel polypeptide-human retinoic acid-responsive protein 53.57 and a polynucleotide encoding the same |
| 09/23/2004 | US20040185441 obtained from Coleoptera having a luciferin-luciferase reaction by culturing transformant/transductant; genetic engineering |
| 09/23/2004 | US20040185440 include the commercially valuable human insulin, interferon, Factor VIII, human growth hormone, tissue plasminogen activator, and erythropoeitin; for drug screening |
| 09/23/2004 | US20040185439 using polymorphisms to determine susceptibility cancer, osteoporosis, cardiovascular disorders; for drug screening |
| 09/23/2004 | US20040185436 chimeric immunoglobulin for detecting hepatitis c viral (HVC) infections and/or contaminated blood products; diagnosis and viral diseases; kits |
| 09/23/2004 | US20040185435 Molecular sequence of swine retrovirus and methods of use |
| 09/23/2004 | US20040185428 Lectin protein prepared from korean marine crab philyra pisum, process for preparing the same and the use thereof |
| 09/23/2004 | US20040185113 Sparingly water-soluble calcium-containing inorganic microparticles and a drug or biodrug encapsulated therein; made by adding a calcium compound to a solution of a carbonate, phosphate, oxalate or urate and the drug to form the calcium salt of the carbonate, phosphate, oxalate or urate |
| 09/23/2004 | US20040185094 Intermediate conductance calcium-activated potassium (IKCa) channel modulator; relaxants of corpus cavernosal smooth muscle; drug screening |
| 09/23/2004 | US20040185064 Method of vaccination through serotype rotation |
| 09/23/2004 | US20040185061 Redox reversible HCV proteins with native-like conformation |
| 09/23/2004 | US20040185060 Immunological enhancement agent comprising N-terminal peptide of p43 as an effective component |
| 09/23/2004 | US20040185059 Biotin-binding receptor molecules |
| 09/23/2004 | US20040185048 Modulation of IL-2- and IL-15-mediated T cell responses |
| 09/23/2004 | US20040185046 Methods of treating autoimmune disease via CTLA-4Ig |
| 09/23/2004 | US20040185044 Use of human antibody which recognises apolipoprotein CIII; atherosclerosis or dyslipidaemia treatment; passive vaccination |
| 09/23/2004 | US20040185042 method for highly selective removal of anti-vWF-cp-abs from human plasma using adsorbent comprises hvWF-cp or fragments thereof, coupled to an inert matrix material |
| 09/23/2004 | US20040185038 loss of immunogenicity is achieved by amino acid substitution, addition or deletion, conducted at a position which in the non-modified polypeptide remains uncleaved by a protease of the MHC class II proteolytic pathway |
| 09/23/2004 | US20040185033 Tumor antigens and CTL clones isolated by a novel procedure |
| 09/23/2004 | US20040185012 peptide is disclosed which is shown to have a novel effect in respect of its anti-microbial activity against periodontal pathogens |
| 09/23/2004 | DE29724845U1 Use of troponin subunits as angiogenesis inhibitors - used for treating e.g. tumours, ocular neovascularisation, arthritis, psoriasis, atherosclerotic plaques or nonunion fractures |
| 09/23/2004 | DE10310758A1 Identifying compounds that modulate sensory neuron specific receptors, useful for treating pain, also nucleic acid encoding the receptors, related proteins and their modulators |
| 09/23/2004 | DE10309866A1 Screening compounds for antifungal activity, particularly against Candida albicans, from their ability to alter expression or activity of fungal homologs of the Wiskott-Aldrich syndrome protein |
| 09/23/2004 | DE10309555A1 New peptide chain release factor B, useful for improving recombinant protein production in bacteria, also a more active variant and related nucleic acids, vectors and cells, accelerates release of proteins from the ribosome |
| 09/23/2004 | DE10262050A1 Genetische Varianten im MMP-2 Gen als ätiologische Faktoren verschiedener Erkrankungen Genetic variants in the MMP-2 gene as etiological factors of various diseases |